This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yamachika, T. Articles by Itzkowitz, S. Search for Related Content PubMed PubMed Citation Articles by Yamachika, T. Articles by Itzkowitz, S.

Intestinal Trefoil Factor

A Marker of Poor Prognosis in Gastric Carcinoma¹

Gastrointestinal Research Laboratory, Departments of Medicine [T. Y., J. L. W., M. B., A. C., S. I.] and Biomathematical Sciences [C. B.], Mount Sinai School of Medicine, New York, New York 10029, and Laboratory of Pathology [M. T.] and Department of Surgery [Y. Y.], Aichi Cancer Center, Nagoya 464, Japan

Purpose: Intestinal trefoil factor (ITF) is a marker of intestinal differentiation that may also play a role in cancer cell biology by inhibiting cell adhesion, promoting cell invasion, and blocking apoptosis. Gastric adenocarcinomas can arise through a process of intestinalization, but no study has yet comprehensively examined the expression of ITF in gastric cancer or correlated ITF expression with clinical outcome in any cancer type.

Experimental Design: Patients (209) with primary gastric adenocarcinoma were evaluated for ITF expression by immunohistochemistry. Results of immunostaining were correlated with clinicopathological variables and overall survival.

Results: In normal gastric mucosa, ITF expression was absent, whereas areas of intestinal metaplasia revealed strong ITF expression by goblet cells. A portion of gastric cancers (55%) demonstrated ITF expression. Women were more likely than men to express ITF in gastric cancers. However, in men, the expression of ITF correlated with aggressive phenotype of tumors (advanced stage, infiltrative growth pattern, and positive lymph nodes). Multivariate analysis revealed that expression of ITF was associated with a poor prognosis, independent of tumor stage.

Conclusions: This is the first study to correlate ITF expression with clinicopathological features or outcome in any cancer type. ITF expression in gastric cancer exhibited a curious gender-associated relationship, being more frequently expressed in tumors of women, but associated with more aggressive pathological features in men. The poor prognosis of patients with ITF-positive gastric cancers further implicates ITF in cancer cell biology.

This article has been cited by other articles:

				M. R. Patel, P. C. Bryson, C. G. Shores, C. F. Hart, L. B. Thorne, A. M. Deal, and A. M. Zanation Trefoil Factor 3 Immunohistochemical Characterization of Follicular Thyroid Lesions From Tissue Microarray Arch Otolaryngol Head Neck Surg, June 1, 2009; 135(6): 590 - 596. [Abstract] [Full Text] [PDF]

				J.-H. Kim, Y.-J. Boo, J.-M. Park, S.-S. Park, S.-J. Kim, C.-S. Kim, and Y.-J. Mok Incidence and Long-term Outcome of Young Patients With Gastric Carcinoma According to Sex: Does Hormonal Status Affect Prognosis? Arch Surg, November 1, 2008; 143(11): 1062 - 1067. [Abstract] [Full Text] [PDF]

				S. F. Moss, J.-W. Lee, E. Sabo, A. K. Rubin, J. Rommel, B. R. Westley, F. E.B. May, J. Gao, P. A. Meitner, R. Tavares, et al. Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis Clin. Cancer Res., July 1, 2008; 14(13): 4161 - 4167. [Abstract] [Full Text] [PDF]

				D. K. Dhar, T. C. Wang, H. Tabara, Y. Tonomoto, R. Maruyama, M. Tachibana, H. Kubota, and N. Nagasue Expression of Trefoil Factor Family Members Correlates with Patient Prognosis and Neoangiogenesis Clin. Cancer Res., September 15, 2005; 11(18): 6472 - 6478. [Abstract] [Full Text] [PDF]